Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS Mutations.

Blaj C, Schmidt EM, Lamprecht S, Hermeking H, Jung A, Kirchner T, Horst D.

Cancer Res. 2017 Apr 1;77(7):1763-1774. doi: 10.1158/0008-5472.CAN-16-2821. Epub 2017 Feb 15.

PMID:
28202525
2.

ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer.

Blaj C, Bringmann A, Schmidt EM, Urbischek M, Lamprecht S, Fröhlich T, Arnold GJ, Krebs S, Blum H, Hermeking H, Jung A, Kirchner T, Horst D.

Clin Cancer Res. 2016 Nov 30. doi: 10.1158/1078-0432.CCR-16-1604. [Epub ahead of print]

PMID:
27903678
3.

CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.

Woischke C, Blaj C, Schmidt EM, Lamprecht S, Engel J, Hermeking H, Kirchner T, Horst D.

Oncotarget. 2016 May 24;7(21):31350-60. doi: 10.18632/oncotarget.8912.

4.

Dendritic cells activated by IFN-γ/STAT1 express IL-31 receptor and release proinflammatory mediators upon IL-31 treatment.

Horejs-Hoeck J, Schwarz H, Lamprecht S, Maier E, Hainzl S, Schmittner M, Posselt G, Stoecklinger A, Hawranek T, Duschl A.

J Immunol. 2012 Jun 1;188(11):5319-26. doi: 10.4049/jimmunol.1101044. Epub 2012 Apr 25.

Supplemental Content

Loading ...
Support Center